meta introduction

11
Wilbert Bannenberg Technical Director International MeTA Secretariat 5 September 2009, FIP 2009 Congress, Istanbul Medicines Transparency Alliance (MeTA) MeTA FIP 05/09/2009 1

Upload: metapresents

Post on 22-Jan-2015

652 views

Category:

Health & Medicine


1 download

DESCRIPTION

Presentation by Wilbert Bannenberg, Technical Director, International MeTA Secretariat on MeTA during the 69th FIP Congress, Istanbul, September 2009.

TRANSCRIPT

  • 1. Wilbert Bannenberg Technical Director International MeTA Secretariat 5 September 2009, FIP 2009 Congress, Istanbul Medicines Transparency Alliance (MeTA) MeTA FIP 05/09/2009

2. What is MeTA?

  • An international alliance between:
    • DFID, World Bank, WHO, private sector, NGOs, professional organisations.
  • Alliances in 7 pilot countries to focus on what can be done to increase access to medicines.
    • - Government, CSOs and Private Sector
  • An International Secretariat to support country work, and, upon request, technical assistance.

05/09/2009 MeTA FIP 3. What does MeTA want to achieve?

  • MeTA goal: toincrease access to essential medicines,especially for the poor in developing countries
  • Essential medicines still valid concept
  • But, after 30 years, 2 billion people are still not having access
  • What can we do better?

05/09/2009 MeTA FIP 4. Added value of MeTA?

  • Country led, bottom-up approach
  • Multi-stakeholder collaboration
  • Improvedtransparencyanddisclosureof all players should lead to betterinformation& greateraccountabilityin the supply chain

05/09/2009 MeTA FIP 5. The scope of MeTA

  • Currently 7 countries are piloting MeTA (until September 2010)
  • Global collaboration with private sector, NGOs, donors and professional organisations

05/09/2009 MeTA FIP 6. Transparency?

  • Improving information access, scrutiny and use, in order to support the development of viable, efficient medicines markets and supply systems that benefit all developing country consumers
  • Transparency =not only disclosureof the price, quality of medicines; but also:
    • Jointlyuse the informationto identify barriers, and
    • Jointly seek bettersolutions!

MeTA FIP 05/09/2009 7. Drug Supply Transparent? Source: SSDS Inc for the World Bank 8. Transparent? 05/09/2009 MeTA FIP Source: TI Global corruption report 2006 9. Areas where transparency can help 05/09/2009 MeTA FIP Source: TI Global corruption report 2006 10. Transparency in pharmacy practice?

  • Transparencyshould be an integral part of Good Pharmacy Practice!
  • Pharmacistscan help in both public and private sector
  • Welcome in MeTA!

05/09/2009 MeTA FIP 11. Contact?

  • Wilbert Bannenberg
  • [email_address]
  • Mobile: +31-6-20873123
  • MeTA website:www.MedicinesTransparency.org

MeTA FIP 05/09/2009